WELLTOWER INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WELLTOWER INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.84B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $7.99B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $6.64B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $5.86B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $4.74B | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | $1.12B | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | $1.04B | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | $1.19B | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | $1.26B | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | $1.26B | Feb 10, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.45B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $6.03B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $4.75B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $4.17B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $3.20B | Feb 15, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $217.61M | Feb 17, 2012 |
| FY2011 | Dec 31, 2010 | $128.53M | Feb 17, 2012 |
| FY2011 | Dec 31, 2009 | $193.27M | Feb 17, 2012 |
| FY2010 | Dec 31, 2008 | $283.30M | Mar 24, 2011 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.75B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $235.49M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $179.09M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $150.39M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $126.73M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $128.39M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $126.55M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $126.38M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $122.01M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $155.24M | Feb 25, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.88B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.26B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.60B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.33B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.28B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $1.36B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $1.54B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $1.58B | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $1.43B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $1.64B | Feb 25, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.30B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $51.04B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $44.01B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $37.89B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $34.91B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $32.48B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $33.38B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $30.34B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $27.94B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $28.87B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.10B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $18.47B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $17.64B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $16.50B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $15.91B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $15.26B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $16.40B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $14.33B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $12.64B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $13.19B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.13B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $31.96B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $25.40B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $20.29B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $17.64B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $15.97B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $15.54B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $14.63B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $14.42B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $14.81B | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $346.32M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $149.23M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $68.32M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $68.32M | Feb 12, 2025 |
| FY2022 | Dec 31, 2021 | $68.32M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $68.32M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $68.32M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $68.32M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $68.32M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $68.32M | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.03B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $10.10B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $9.15B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $8.80B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $8.66B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $8.33B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $7.35B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $6.12B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $5.32B | Feb 25, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.03B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $3.51B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.99B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $631.68M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $269.27M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.55B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $284.92M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $215.38M | Feb 14, 2020 |
| FY2020 | Jul 26, 2018 | $381.91M | Feb 10, 2021 |
| FY2018 | Dec 31, 2017 | $243.78M | Feb 25, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.20B | Feb 12, 2026 |
| FY2024 | Dec 31, 2024 | $15.50B | Feb 12, 2025 |
| FY2023 | Dec 31, 2023 | $15.74B | Feb 15, 2024 |
| FY2022 | Dec 31, 2022 | $14.71B | Feb 21, 2023 |
| FY2021 | Dec 31, 2021 | $13.91B | Feb 16, 2022 |
| FY2021 | Dec 31, 2020 | $2.38B | Feb 16, 2022 |
| FY2019 | Dec 31, 2019 | $13.42B | Feb 14, 2020 |
| FY2018 | Dec 31, 2018 | $12.19B | Feb 25, 2019 |
| FY2017 | Dec 31, 2017 | $11.04B | Feb 28, 2018 |
| FY2016 | Dec 31, 2016 | $11.73B | Feb 22, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 10, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 10, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 696.51M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 635.29M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 564.24M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 490.51M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | 447.24M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | 417.40M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | 410.26M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | 383.67M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | 371.73M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | 362.60M | Feb 28, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.88B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.55B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.26B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.13B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.04B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $1.12B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $1.40B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $1.30B | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $1.28B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $1.23B | Feb 25, 2019 |